about
Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.[Lung disease in adult common variable immunodeficiency].[Guidelines for the management of dasatinib (Sprycel)-induced side effects in chronic myelogenous leukemia and Philadelphia positive acute lymphoblastic leukemias].New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards.Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trialIatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.Obliterative bronchiolitis.Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.CT Imaging Assessment of Response to Treatment in Chronic Pulmonary Aspergillosis.Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study.Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation.[Respiratory infections caused by slow-growing bacteria: Nocardia, Actinomyces, Rhodococcus].Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation.[Small airway diseases and immune deficiency].Human metapneumovirus pneumonia in patients with hematological malignancies.Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation.Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.The pulmonologist's point of view on lung infiltrates in haematological malignancies.Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis.Myocardial ischemia and infarction associated with vinorelbine.Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.[Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation].[Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders.]Phenotyping chronic pulmonary aspergillosis by cluster analysis.Clinical characteristics and prognostic factors of pulmonary MALT lymphoma.Dasatinib-induced lupus.Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry.Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum.Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.The prognosis of acute respiratory failure in critically ill cancer patients.Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease.Bosutinib-related pneumonitis.Azithromycin and Survival After Hematopoietic Stem Cell Transplant-Reply.Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation.[Allergic bronchopulmonary aspergillosis: Evaluation of a maintenance therapy with nebulized Ambisome®].Reply to "Early Lung Computed Tomography Scan after Allogeneic Hematopoietic Stem Cell Transplantation".The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies.
P50
Q30234549-4C5F53DE-6134-4E40-8F42-E705679ACC7FQ31087724-FD624182-46A3-4A17-A13A-B7A013669154Q33900089-814D366F-0F8B-4E5E-8E3A-5FB0F63A35DAQ34042225-378C6E77-2441-4B05-A770-0B68ED5B636FQ34480587-A436C761-8845-445F-81B4-A544AAE4222AQ34597819-83B739EF-891D-458C-8E3A-293DD810C115Q35561221-30887783-E026-4D6A-A420-A4442C5DAEEFQ36342188-BAB371F1-9685-4283-A128-DFE96D9B9DC1Q37409009-2F7DD3E3-7237-48C0-9FE1-4CD10183D8CEQ38210037-E96E796D-9F32-4852-9BA7-59C0AF6869E2Q38372551-15BDAAB5-1AD6-43FC-8269-352F8C99696CQ38904622-4E3D963B-82BF-434B-8076-3A7854E63583Q40105015-1050FD34-D03B-46B1-86C1-A871DB1EFEE7Q40105412-64918C1C-75B0-4DD3-AF2C-9D29A0580B5BQ40130900-0347BDA3-5798-4F98-B379-6FB71F6B60E6Q40420994-AAF574A6-3A99-4880-872B-DE0AFFB15C53Q40801160-44D8CC40-F2D1-47E9-AC0F-62F7C7976E1FQ41640118-189A6D96-8EF3-41BD-AEEF-9A27FEE92B4AQ41908744-1CC8B05E-271C-43EE-8AD1-97C0894389D2Q42213740-DA8AF971-3353-4405-AB09-E15B2EA9A241Q42279850-DE9E6A00-55B5-48F5-B9B9-4B3B37CDF391Q42284049-DEFDBAA9-8582-4B13-A7A2-B16F7A64DFB8Q42564084-D23E8EE6-C5DE-4547-BC76-57A284485A9AQ43085642-9B87BB0E-4A09-44C3-A773-E0BC86E5CED6Q43232444-B8AC850D-5363-47F1-A571-733E0CC10238Q43992058-C4F936AC-ECAE-43E2-AE92-D3D4AD522B15Q44025490-7D39EBB7-862C-46E3-96A4-1A276084E1B1Q45420908-D53DABAC-5257-4E81-9951-55EB2F0362D4Q46399324-F821616C-F4BB-4D7A-B6A2-BE04F71EE6C8Q46766257-4444B94D-AE88-404B-9D58-43C4B606DE94Q47140701-FD8C3039-D5DF-4100-960A-6E8AE881422FQ47664019-685F1194-347E-4975-9C67-72620BB6B117Q47900767-2884879F-FDC9-4162-A6CA-27DC9075F6C0Q48259698-B201BE0F-708E-46C6-A8BA-8D5317DE2237Q48359362-503B9BDE-CAC1-4367-91C4-711A7AC9901DQ49565173-7A1ABCD9-4252-4BC0-B044-5529D3714027Q51695019-4142DD4D-B73E-4236-AD01-43A8AB8AB277Q52864643-EDF3DFE8-41F7-44DD-B5C5-63E1DF145B7DQ52981282-B9B74FBE-677D-4FB9-AC32-849F0AE6AA9FQ53195957-006DFE1B-8A84-4A32-88ED-C39D47EA651C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anne Bergeron
@ast
Anne Bergeron
@en
Anne Bergeron
@es
Anne Bergeron
@nl
Anne Bergeron
@sl
type
label
Anne Bergeron
@ast
Anne Bergeron
@en
Anne Bergeron
@es
Anne Bergeron
@nl
Anne Bergeron
@sl
prefLabel
Anne Bergeron
@ast
Anne Bergeron
@en
Anne Bergeron
@es
Anne Bergeron
@nl
Anne Bergeron
@sl
P106
P21
P31
P496
0000-0003-2156-254X